Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323309 · ClinicalTrials.gov registry record
Trial of Individual Psychosocial Interventions for Cancer Patients
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 346
- Enrollment target
NCT01323309: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01323309 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 346 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01323309 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 346 participants
- Enrollment target
Study Summary
The aim of the study is to compare the benefits of three types of individual treatment programs for cancer patients: Meaning-Centered counseling, Supportive counseling, and Enhanced Usual Care. We would like to train therapists in administering these types of counseling, so that they have expertise to work on the study. The therapists will administer either the Meaning-Centered counseling or the Supportive counseling, as part of their training. Many cancer patients use counseling or other resources to help with the emotional burden of their illnesses. Counseling often helps them cope with cancer by giving them a place to express their feelings. "Meaning-Centered" counseling aims to teach cancer patients how to maintain or even increase a sense of meaning and purpose in their lives, despite cancer. "Supportive" counseling is intended to help the patient cope with cancer by giving them a place to express their feelings and get support. Enhanced Usual Care is intended to offer the patient referrals and resources that are matched to their individual needs in addition to the care they are already receiving at MSKCC.
Primary Outcome
The Life Attitude Profile-Revised (LAP-R) is a 48-item self-report measure of discovered meaning and purpose in life and the motivation to find meaning and purpose in life. There are 6 subscales: Purpose (8 items, Minimum 8, Maximum 56, Higher is better), Coherence (8 items, Minimum 8, Maximum 56, Higher is better), Life control (8 items, Minimum 8, Maximum 56, Higher is better), Death acceptance (8 items, Minimum 8, Maximum 56, Higher is better), Existential transcendence (16 items, Minimum 16,
Interventions
- BEHAVIORAL Individual Meaning-Centered Psychotherapy (IMCP)
- BEHAVIORAL standard Individual Supportive Psychotherapy (ISP)
- BEHAVIORAL enhanced usual care (EUC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2011-03-22 |
| Est. Completion | 2023-02-22 |
What the finished NCT01323309 record still lists
NCT01323309 is an observational study that tracks outcomes without assigning an intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Individual Meaning-Centered Psychotherapy (IMCP) is the first listed.
NCT01323309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01323309 about?
NCT01323309 is a clinical study titled "Trial of Individual Psychosocial Interventions for Cancer Patients". The aim of the study is to compare the benefits of three types of individual treatment programs for cancer patients: Meaning-Centered counseling, Supportive counseling, and Enhanced Usual Care. We would like to train therapists in administering these types of counseling, so that they have expertise...
What is the current status of trial NCT01323309?
This trial is currently completed. The enrollment target is 346 participants. The study started on 2011-03-22. Estimated completion is 2023-02-22.
What interventions are being tested in trial NCT01323309?
The interventions under investigation include: Individual Meaning-Centered Psychotherapy (IMCP) (BEHAVIORAL), standard Individual Supportive Psychotherapy (ISP) (BEHAVIORAL), enhanced usual care (EUC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01323309?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267886 · 346 participants · Phase 4
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
- NCT06705842 · 346 participants · Phase 4
APPI-Cost Trial for Perforated Appendicitis
- NCT06932887 · 346 participants · Phase 3
The Beat Pain Better Trial
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI